Prairiewood Capital, LLC Innoviva, Inc. Transaction History

Prairiewood Capital, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 16, 2024	SELL	$12.32 - $16.27 $65,012 - $85,856	-5,277 Reduced 7.4%	65,988 $1.06 Million
Q3 2023 Oct 12, 2023	SELL	$12.37 - $13.89 $569 - $638	-46 Reduced 0.06%	71,265 $925,000
Q2 2023 Jul 24, 2023	SELL	$11.39 - $13.72 $66,130 - $79,658	-5,806 Reduced 7.53%	71,311 $907,000
Q1 2023 Apr 19, 2023	SELL	$10.73 - $13.6 $5,075 - $6,432	-473 Reduced 0.61%	77,117 $867,000
Q4 2022 Jan 20, 2023	SELL	$11.8 - $13.78 $10,336 - $12,071	-876 Reduced 1.12%	77,590 $0
Q2 2022 Jul 13, 2022	SELL	$14.32 - $19.88 $24,959 - $34,650	-1,743 Reduced 2.17%	78,466 $1.16 Million
Q1 2022 Apr 20, 2022	SELL	$15.39 - $20.25 $12,034 - $15,835	-782 Reduced 0.97%	80,209 $1.55 Million
Q4 2021 Jan 20, 2022	SELL	$15.91 - $18.72 $26,156 - $30,775	-1,644 Reduced 1.99%	80,991 $1.4 Million
Q3 2021 Oct 13, 2021	SELL	$13.06 - $17.24 $11,884 - $15,688	-910 Reduced 1.09%	82,635 $1.38 Million
Q2 2021 Jul 13, 2021	BUY	$11.45 - $13.96 $469 - $572	41 Added 0.05%	83,545 $1.12 Million
Q1 2021 Apr 13, 2021	SELL	$11.06 - $12.87 $8,261 - $9,613	-747 Reduced 0.89%	83,504 $998,000
Q4 2020 Jan 15, 2021	BUY	$9.33 - $12.48 $786,061 - $1.05 Million	84,251 New	84,251 $1.04 Million

227

78.9M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.23B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Prairiewood Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Prairiewood Capital, LLC with notifications on news.